NEW YORK — The morning after presenting an upbeat outlook to analysts in a gilded hall in the New York Stock Exchange building, Mick Farrell, the CEO of ResMed, looked refreshed, despite a post ...

Learn More ResMed (ASX: RMD) shares are outperforming the market on Tuesday. In afternoon trade, the sleep disorder treatment company's shares are up 2% to $35.73. This compares favourably to a 0. ...

ResMed’s CPAP (continuous positive airway pressure) product, the AirFit N20. The California-based company, founded by Mr Farrell’s father in Sydney 35 years ago, is also listed on the ASX.

Learn about our editorial policies The exact nature and causes of supply shocks are imperfectly understood. The most common explanation is that an unexpected event causes a dramatic change in ...

such as the AirTouch N30i next-generation CPAP mask unveiled earlier today. Capitalize on ResMed’s market opportunity and brand advantage in broader sleep health and breathing health adjacencies ...

With interactive coaching and nightly sleep data tracking, MyAir helps increase CPAP usage, with 87% of patients achieving therapy compliance. (ResMed also launched a new CPAP mask today — read ...

[Image courtesy of ResMed] ResMed (NYSE: RMD) + announced today that it launched its new AirTouch N30i continuous positive airway pressure (CPAP) mask. ResMed says it developed the AirTouch N30i ...

Sept. 30, 2024 /PRNewswire/ -- Gogo Inc. (NASDAQ: GOGO) ("Gogo" or the "Company") and Satcom Direct today announced entry into a definitive agreement under which Gogo will acquire Satcom Direct to ...

After the big Covid-19 whipsaw, the most obvious forms of supply chain distress started to fade away. But the relative peace and quiet that executives are perceiving is actually ominous.

PERRY, Florida — The U.S. Southeast grappled Sunday with rising death tolls, a lack of vital supplies in isolated, flood-stricken areas and the widespread loss of homes and property while the ...